Purpose: Fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is common in Asia, especially in China and Southeast Asia. There are no data about fecal carriage of ESBL-EC and mcr-1-positive E. coli in Taiwan, and few studies focusing on the risk factors of asymptomatic fecal carriage of epidemic ST131 E. coli have been published. Patients and methods: From healthy inhabitants attending health examinations at a medical center in southern Taiwan in 2017, we collected 724 stool samples, which were examined for ESBL-EC fecal carriage using chromogenic medium. ST131 and mcr1-positive E. coli were also investigated using multiplex PCR. Clinical data from all participating adults were collected to analyze the risk factors for fecal ESBL-EC or ST131 E. coli carriage. Results: The prevalence rate of asymptomatic ESBL-EC fecal carriage in adults was 1.9% (14/724). ST131 was found in 22 (3.0%) adults and mcr-1-positive E. coli was found in three (0.4%) adults. A multivariate analysis showed that the risk factors associated with ESBL-EC carriage were diabetes mellitus (adjusted odds ratio [aOR]: 5.5, 95% confidence interval [CI]: 1.3-22.7), a history of colonic polyps (aOR: 6.4, 95% CI: 1.6-24.9), and chronic renal insufficiency (aOR: 20.7, 95% CI: 1.4-305.7). Underlying cancer (aOR: 4.8, 95% CI: 1.0-22.5) and stroke (aOR: 18.0, 95% CI: 1.6-207.5) were associated with ST131 E. coli fecal carriage. In our cohort, travel to Asian countries and food habit were not associated with ST131 or ESBL-EC fecal carriage. Conclusions: The ESBL-EC or ST131 E. coli fecal carriage rate is low among asymptomatic adults in Taiwan. Certain underlying medical conditions were associated with their fecal carriage.
Introduction
Escherichia coli is a normal inhabitant in the human gastrointestinal tract. However, it is also an important pathogen in adults. In previous decades, the occurrence of extended-spectrum beta-lactamases (ESBL)-producing Enterobacteriaceae, which causes treatment failure of cephalosporin therapy, has become a remarkable epidemiological event. The prevalence of ESBL-E.coli (ESBL-EC) fecal carriage in healthy adults has been increasing alarmingly, at an annual rate of 5.4% worldwide. 1 Recently, the prevalence of asymptomatic ESBL-EC carriage was about 5-8% in Europe, 2% in America, 6% in Japan, 19% in India, 30% in China, and 30-50% in Thailand. [2] [3] [4] [5] [6] Antibiotic exposure within 6 months, daily animal contact, or travelling to Africa or Asia, had been linked to asymptomatic ESBL-EC fecal carriage. [2] [3] [4] [5] [6] Colistin was considered to be the last-line antimicrobial agent for treating patients with multidrugresistant bacteria, 7, 8 but in 2015, the plasmid-mediated colistin resistance gene, mcr-1, was first described in China. Since then, mcr-1 has been identified in the environment, animals, and humans. 7 However, there are no data on fecal carriage of ESBL-EC and mcr-1 E. coli in asymptomatic people in other Asian regions including Taiwan. Moreover, few studies have focused on the risk factors for fecal carriage of ST131 E. coli, an epidemic strain, in the asymptomatic population. Therefore, the aims of this study were to determine the prevalence and risk factors for asymptomatic carriage of ESBL-EC, mcr-1 E. coli, or ST131 E. coli in Taiwan.
Materials and methods Participants
This study was conducted from April 2016 to June 2017 at the health check center in Kaohsiung Veterans General Hospital, which is located in southern Taiwan. All individuals visiting the health check center routinely fill out a standardized questionnaire, which including demographic data, personal history, medical history, and underlying chronic illness (such as peptic ulcer or colonic polyps, antibiotic therapy, or probiotic use in the past 3 months), boiled or unboiled drinking water, and diet habits. The aforementioned data was recorded by one physician at our center during health exam interview. The participants were randomly selected and their residual fecal samples for fecal occult blood tests were collected. Only individuals whose data in the dataset of the questionnaires was intact were included in this study. Hyperuricemia was defined as a serum uric acid level ≥7 mg/dL, 9 and chronic renal diseases were defined as serum creatinine >1.5 mg/dL. With a high prevalence of ESBL-EC in Asia, especially in Southeast Asia, India, and China, we also collected the participants' travel information. [2] [3] [4] [5] [6] The study was approved by the Ethics Committee at the Kaohsiung Veterans General Hospital (VGHKS16-CT2-04). The ethics committee waived the need for written informed consent provided by participants due to the noninterventional and retrospective nature of the study. Because all patient data were analyzed in anonymity, no additional informed consent was required.
Isolation of bacteria and microbiological analysis
Each stool sample was spread on a CHROMagar™ ECC plate (CHROMagar, Paris, France) and incubated at 37°C for 24 h and up to two E. coli colonies were selected. If the colony color was dark pink to reddish, it was spread onto a CHROMagar™ ESBL plate (CHROMagar, Paris, France) to identify ESBL-EC isolates. ESBL genes, including bla CTX-M , bla SHV , bla TEM , bla OXA-1 , bla IMP , and bla VIM , were assessed using the polymerase chain reaction (PCR) using previously described primers and methods, 
Results
During the study period, fecal occult blood tests were performed in 5,042 individuals. Among them, 743 individuals were randomly selected for enrollment and 724 participants were finally included in the study due to 19 individuals with incomplete data in the dataset of the questionnaires. There were 513 E. coli isolates found in the stool in the PCR study. The participants' mean age was 46.9 years, and females predominated, accounting for 52.1% of the study population. In the univariate analyses, two variables were associated with asymptomatic ESBL-EC fecal carriage: diabetes mellitus (OR 6.6, 95% CI 1.8-25.2) and colonic polyps (OR 6.0, 95% CI 1.6-22.5; Table 1 ). The multivariate logistic regression model showed that diabetes mellitus (aOR 5.5, 95% CI 1.3-22.7), colonic polyps (aOR 6.4, 95% CI 1.6-25.0), and chronic renal insufficiency (aOR 20.7, 95% CI 0.4-305.7) were significantly associated with ESBL-EC carriage (Table 1) . Among 14 isolates with the ESBL-production phenotype, six isolates had bla TEM , six had bla SHV , four had bla CTX-M , one had bla VIM , one had bla OXA-1 , and one had bla IMP (Table 2) . Five isolates had more than one ESBL gene. The major CTX-M enzyme was CTX-M-14, which was found in three isolates. Among 14 isolates of ESBL-EC, the sequence types (STs) included ST131 (n=2), S1193 (n=2), ST10 (n=1), ST38 (n=1), ST101 (n=1), ST127 (n=1), ST349 (n=1), ST410 (n=1), ST963 (n=1), ST1972 (n=1), ST2607 (n=1), and S3045 (n=1).
Underlying disease of cancer (OR 4.8, 95% CI 1.02-22.5) or stroke (OR 18.0, 95% CI 1.6-207.5) was associated with asymptomatic ST131 E. coli fecal carriage using the univariate analysis and multivariable logistic regression analysis (Table 3) .
For antibiotic susceptibility, ST131 isolates had a higher resistance rate to cefazolin (68.2% vs 58.6%, P=0.380), ceftriaxone (22.7% vs 9.7%, P=0.070), and levofloxacin (50% vs 29.5%, p=0.045) than non-ST131 isolates. ESBL-EC isolates were more likely to be resistant to cefazolin (92.9% vs 57.7%, P=0.009), ceftriaxone (78.6% vs 7.3%, P<0.001), and levofloxacin (42.9% vs 30.4%, P=0.377) than non-ESBL-EC isolates.
mcr-1 was identified in three E. coli isolates, which were not ST131 or ESBL-EC. The prevalence of fecal mcr-1 E. coli carriage was 0.4% (3/724). Clinical characteristics of the three subjects with fecal mcr-1E. coli carriage and E. coli isolates with colistin MICs and STs are shown in Table 4 . All three subjects were healthy without chronic underlying diseases, but one had traveled to China within the past year. Three isolates were susceptible to piperacillin/tazobactam, cefazolin, cefmetazole, cefotaxime, ceftazidime, cefepime, ertapenem, meropenem, imipenem, amikacin, gentamycin, ciprofloxacin, levofloxacin, and tigecycline. The colistin MIC in three isolates was 2, 2, and 4 mg/L, respectively (Table 4) .
Discussion
The prevalence and risk factors for ESBL-EC carriage in asymptomatic individuals have been described previously in many regions of the world. [2] [3] [4] [5] [6] In this study, the prevalence of ESBL-EC carriage in healthy people in Taiwan was about 2%, lower than those in other areas of Asia. We found that people with a medical history of diabetes mellitus, chronic renal diseases, or colonic polyps had an 21 However, in this study, fecal carriage of ESBL-EC was not associated with meat consumption, unboiled water use, occupation in the health care setting, or daily animal contact, and previous antibiotic use did not increase the risk of ESBL-EC carriage in asymptomatic people. These results were consistent with previous studies. 4, 6, 22 In a systemic review and meta-analysis, travelling to Asia and Africa was linked to fecal colonization with ESBL-EC, 1 which cannot be confirmed in our cohort. It is not surprising because most studies showing a positive relationship between travelling and ESBL-EC carriage were conducted in Europe and North America, 23 and our participants were Taiwanese who had more opportunities to meet Asians or visit other environments, which decreased the impact of travel on ESBL-EC carriage.
The ST131 E. coli clone is an important cause of fluoroquinolone-resistant E. coli infections, 24 which is consistent with our result that levofloxacin resistance was more common in ST131 E. coli. The emergence of ST131 in the community would pose a challenge to empirical therapy for many community-acquired infections. ST131 transmission among people was documented after household contact with ST131 carriers, 25 highlighting the potential health impact of ST131 carriers. However, few studies focused on the risk factors for epidemic ST131 E. coli carriage in the asymptomatic population. In this study, individuals with underlying cancer or stroke had a higher risk of ST131 E. coli carriage. A previous study in Korea reported that ST131 was the most common sequence type of ESBL-EC bacteremia in cancer patients, 26 suggesting an increased susceptibility to ST131 colonization in these patients. However, to the best of our knowledge, there is no evidence suggesting that people with prior stroke had an increased risk of ST131E. coli carriage; this warrants further confirmation. Moreover, we found that drinking boiled water tended to protect against ST131E. coli carriage (75% vs 59%; P=0.09). Human ST131 carriage has been relevant to the water source of ST131 isolates. 27, 28 However, direct evidence to verify that unboiled water is the source of ST131 E. coli
have not yet been found. In Taiwan, mcr-1-harboring Enterobacteriaceae isolates have been found in patients and food-producing animals. 8, 15, 29, 30 A recent study including ten cases of mcr-1-harboring Enterobacteriaceae bacteremia revealed that 50% of them were hospitalized within 3 months before bacteremia episodes and most subjects had chronic diseases. 15 Notably, all ten patients denied recent travel abroad. Characteristically, our mcr-1-harboring E. coli isolates were discovered from three asymptomatic adults without chronic diseases or recent exposure to antibiotics. The relevance of recent travel to China in Table 2 The distribution of beta-lactamase genes in 14 Escherichia coli isolates with the extended-spectrum beta-lactamse-production phenotype
No.14 ------Note: "+" indicates the presence of specific gene, and "-" indicates the absence. one participant with mcr-1 E. coli carriage remains undefined. Most mcr-1-harboring E. coli isolates were non-wild types, but some wild types were reported. 31, 32 The genetic relationship between our colonized isolates and the previously published isolates causing bloodstream infections or those obtained from pigs in Taiwan 15 warrants further investigation.
In contrast to the prevalence data in China (4.9%) 33 and Hong Kong (2.1%), 34 fecal mcr-1 E. coli carriage in our adults visiting a health examination center was less common (0.4%), which was similar to results from The Netherlands (0.35%). 32 The above data suggest geographic diversity of mcr-1 E. coli fecal carriage throughout the world and that mcr-1 E. coli is not widely spread in the community in Taiwan.
There are some limitations to this study. First, the participants only involved urban adults who received health examinations in one city, and the representativeness of the study cohort for the Taiwan population is limited. Second, the number of patients with ESBL-EC and ST131 E. coli carriage was too small to detect certain risk factors. Last, the association of colonic polyps and ESBL-EC may be biased because of recall bias for the diagnosis of colonic polyps. A prospective study enrolling individuals with colonic polyps that were diagnosed by colonoscopy and microbiological screening of fecal ESBL-EC carriage is warranted.
Conclusion
Asymptomatic adults in Taiwan had a low prevalence rate of fecal ESBL-EC or ST131 E. coli carriage, which was associated with the presence of underlying medical conditions. However, only a small number of ESBL-EC and ST131 E. coli isolates were noted in the study, and the associated risk factors require further investigation.
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